-
EP4070810
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4070810
| EP4070810 - METHOD FOR TREATING CANCER USING ARTIFICIAL ADJUVANT VECTOR CELLS (AAVC) [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 09.09.2022 Database last updated on 24.08.2024 | |
| Former | The international publication has been made Status updated on 11.06.2021 | Most recent event Tooltip | 19.03.2024 | Supplementary search report | published on 17.04.2024 [2024/16] | Applicant(s) | For all designated states Astellas Pharma Inc. 5-1, Nihonbashi-Honcho 2-Chome Chuo-ku Tokyo 103-8411 / JP | For all designated states RIKEN 2-1, Hirosawa Wako-shi Saitama 351-0198 / JP | [2022/41] | Inventor(s) | 01 /
OHSUMI Keisuke c/o Astellas Pharma Inc. 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411 / JP | 02 /
YOSHIDA Taku c/o Astellas Pharma Inc. 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411 / JP | 03 /
KANKI Masayuki c/o Astellas Pharma Inc. 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411 / JP | 04 /
FUJII Shinichiro c/o RIKEN 2-1, Hirosawa Wako-shi, Saitama 351-0198 / JP | 05 /
SHIMIZU Kanako c/o RIKEN 2-1, Hirosawa Wako-shi, Saitama 351-0198 / JP | [2022/41] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2022/41] | Application number, filing date | 20897410.5 | 01.12.2020 | [2022/41] | WO2020JP44587 | Priority number, date | JP20190217712 | 02.12.2019 Original published format: JP 2019217712 | [2022/41] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021112056 | Date: | 10.06.2021 | Language: | JA | [2021/23] | Type: | A1 Application with search report | No.: | EP4070810 | Date: | 12.10.2022 | Language: | EN | [2022/41] | Search report(s) | International search report - published on: | JP | 10.06.2021 | (Supplementary) European search report - dispatched on: | EP | 18.03.2024 | Classification | IPC: | A61K39/00, A61K39/39, A61P35/00, A61P37/04, C07K14/705, C12N5/0783, C12N15/12, A61K35/12, A61K35/22 | [2022/41] | CPC: |
A61K35/22 (EP,IL,KR,US);
A61K39/39 (EP,IL,KR,US);
A61K39/001153 (EP,IL,KR,US);
A61P35/00 (EP,IL,KR);
A61P37/04 (EP,IL,KR);
C07K14/435 (EP,IL,KR);
C07K14/705 (EP,IL,KR);
C12N5/06 (EP,IL);
C12N5/0686 (KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/41] | Extension states | BA | 01.06.2022 | ME | 01.06.2022 | Validation states | MA | 01.06.2022 | Title | German: | VERFAHREN ZUM BEHANDELN VON KREBS MIT KÜNSTLICHEN ADJUVANTIERTEN VEKTORZELLEN (AAVC) | [2022/41] | English: | METHOD FOR TREATING CANCER USING ARTIFICIAL ADJUVANT VECTOR CELLS (AAVC) | [2022/41] | French: | MÉTHODE DE TRAITEMENT DU CANCER À L'AIDE DE CELLULES VECTEURS D'ADJUVANT ARTIFICIELLES (AAVC) | [2022/41] | Entry into regional phase | 01.06.2022 | Translation filed | 01.06.2022 | National basic fee paid | 01.06.2022 | Search fee paid | 01.06.2022 | Designation fee(s) paid | 01.06.2022 | Examination fee paid | Examination procedure | 01.06.2022 | Amendment by applicant (claims and/or description) | 01.06.2022 | Examination requested [2022/41] | Fees paid | Renewal fee | 14.12.2022 | Renewal fee patent year 03 | 15.11.2023 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [YD]WO2007097370 (RIKEN [JP], et al); | International search | [Y]WO2007097370 (RIKEN [JP], et al); | by applicant | WO2007097370 | WO2010061930 | WO2013018778 |